Skip to main content
Top
Published in: Intensive Care Medicine 9/2018

01-09-2018 | What's New in Intensive Care

What’s new in ICU in 2050: big data and machine learning

Authors: Sébastien Bailly, Geert Meyfroidt, Jean-François Timsit

Published in: Intensive Care Medicine | Issue 9/2018

Login to get access

Excerpt

The amount of digitalized data that the world produces today is by all measures unseen and spectacular. Social media, e-commerce, and the Internet of things generate approximately 2.5 quintillions of bytes per day, an amount that equals 100 million Blu-ray discs, or almost 30,000 GB per second. Data grows exponentially, and 90% of all data on the Internet has been created since 2016. This trend will continue in the next decades [1]. Such datasets of unimaginable size cannot be maintained with traditional database management technology, or examined with traditional statistical techniques. The general term for methods to manage and analyze such unstructured datasets is “big data”. Although the term is often ill-defined and improperly used, the five “Vs” concept is a good summary: Volume, Velocity, Variety, Veracity, and Value referring to, respectively, the large quantity of data; the speed of acquisition; the diversity of data sources; the uncertain data quality; and the possible valorization. The last of these is without a doubt the “V” that matters most. In medicine, the first datasets amenable to big data were generated when techniques to process genomic data became available, for instance for tumor genotyping in oncology [2]. …
Literature
1.
go back to reference Ffoulkes P (2017) InsideBIGDATA guide to the intelligent use of big data on an industrial scale. InsideBIGDATA, Massachusetts Ffoulkes P (2017) InsideBIGDATA guide to the intelligent use of big data on an industrial scale. InsideBIGDATA, Massachusetts
2.
go back to reference Booth CM, Tannock IF (2014) Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence. Br J Cancer 110:551–555CrossRefPubMedPubMedCentral Booth CM, Tannock IF (2014) Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence. Br J Cancer 110:551–555CrossRefPubMedPubMedCentral
3.
go back to reference Apkon M, Singhaviranon P (2001) Impact of an electronic information system on physician workflow and data collection in the intensive care unit. Intensive Care Med 27:122–130CrossRefPubMed Apkon M, Singhaviranon P (2001) Impact of an electronic information system on physician workflow and data collection in the intensive care unit. Intensive Care Med 27:122–130CrossRefPubMed
5.
go back to reference Murdoch TB, Detsky AS (2013) The inevitable application of big data to health care. JAMA 309:1351–1352CrossRefPubMed Murdoch TB, Detsky AS (2013) The inevitable application of big data to health care. JAMA 309:1351–1352CrossRefPubMed
6.
go back to reference Flechet M, Grandas FG, Meyfroidt G (2016) Informatics in neurocritical care: new ideas for Big Data. Curr Opin Crit Care 22:87–93PubMed Flechet M, Grandas FG, Meyfroidt G (2016) Informatics in neurocritical care: new ideas for Big Data. Curr Opin Crit Care 22:87–93PubMed
7.
go back to reference Simpkin AL, Schwartzstein RM (2016) Tolerating uncertainty—the next medical revolution? N Engl J Med 375:1713–1715CrossRefPubMed Simpkin AL, Schwartzstein RM (2016) Tolerating uncertainty—the next medical revolution? N Engl J Med 375:1713–1715CrossRefPubMed
8.
go back to reference Angus DC (2015) Fusing randomized trials with big data: the key to self-learning health care systems? JAMA 314:767–768CrossRefPubMed Angus DC (2015) Fusing randomized trials with big data: the key to self-learning health care systems? JAMA 314:767–768CrossRefPubMed
9.
go back to reference Mirnezami R, Nicholson J, Darzi A (2012) Preparing for precision medicine. N Engl J Med 366:489–491CrossRefPubMed Mirnezami R, Nicholson J, Darzi A (2012) Preparing for precision medicine. N Engl J Med 366:489–491CrossRefPubMed
10.
go back to reference Perner A, Gordon AC, Angus DC, Lamontagne F, Machado F, Russell JA, Timsit JF, Marshall JC, Myburgh J, Shankar-Hari M, Singer M (2017) The intensive care medicine research agenda on septic shock. Intensive Care Med 43:1294–1305 Perner A, Gordon AC, Angus DC, Lamontagne F, Machado F, Russell JA, Timsit JF, Marshall JC, Myburgh J, Shankar-Hari M, Singer M (2017) The intensive care medicine research agenda on septic shock. Intensive Care Med 43:1294–1305
11.
go back to reference Robins JM, Hernan MA, Brumback B (2000) Marginal structural models and causal inference in epidemiology. Epidemiology 11:550–560CrossRefPubMed Robins JM, Hernan MA, Brumback B (2000) Marginal structural models and causal inference in epidemiology. Epidemiology 11:550–560CrossRefPubMed
12.
go back to reference Bailly S, Bouadma L, Azoulay E, Orgeas MG, Adrie C, Souweine B, Schwebel C, Maubon D, Hamidfar-Roy R, Darmon M, Wolff M, Cornet M, Timsit JF (2015) Failure of empirical systemic antifungal therapy in mechanically ventilated critically ill patients. Am J Respir Crit Care Med 191:1139–1146CrossRefPubMed Bailly S, Bouadma L, Azoulay E, Orgeas MG, Adrie C, Souweine B, Schwebel C, Maubon D, Hamidfar-Roy R, Darmon M, Wolff M, Cornet M, Timsit JF (2015) Failure of empirical systemic antifungal therapy in mechanically ventilated critically ill patients. Am J Respir Crit Care Med 191:1139–1146CrossRefPubMed
13.
go back to reference Timsit JF, Azoulay E, Schwebel C, Charles PE, Cornet M, Souweine B, Klouche K, Jaber S, Trouillet JL, Bruneel F, Argaud L, Cousson J, Meziani F, Gruson D, Paris A, Darmon M, Garrouste-Orgeas M, Navellou JC, Foucrier A, Allaouchiche B, Das V, Gangneux JP, Ruckly S, Maubon D, Jullien V, Wolff M, EMPIRICUS Trial Group (2016) Empirical micafungin treatment and survival without invasive fungal infection in adults with ICU-acquired sepsis, candida colonization, and multiple organ failure: the EMPIRICUS randomized clinical trial. JAMA 316:1555–1564CrossRefPubMed Timsit JF, Azoulay E, Schwebel C, Charles PE, Cornet M, Souweine B, Klouche K, Jaber S, Trouillet JL, Bruneel F, Argaud L, Cousson J, Meziani F, Gruson D, Paris A, Darmon M, Garrouste-Orgeas M, Navellou JC, Foucrier A, Allaouchiche B, Das V, Gangneux JP, Ruckly S, Maubon D, Jullien V, Wolff M, EMPIRICUS Trial Group (2016) Empirical micafungin treatment and survival without invasive fungal infection in adults with ICU-acquired sepsis, candida colonization, and multiple organ failure: the EMPIRICUS randomized clinical trial. JAMA 316:1555–1564CrossRefPubMed
14.
go back to reference Guiza F, Van Eyck J, Meyfroidt G (2013) Predictive data mining on monitoring data from the intensive care unit. J Clin Monit Comput 27:449–453CrossRefPubMed Guiza F, Van Eyck J, Meyfroidt G (2013) Predictive data mining on monitoring data from the intensive care unit. J Clin Monit Comput 27:449–453CrossRefPubMed
15.
go back to reference Flechet M, Guiza F, Schetz M, Wouters P, Vanhorebeek I, Derese I, Gunst J, Spriet I, Casaer M, Van den Berghe G, Meyfroidt G (2017) AKIpredictor, an online prognostic calculator for acute kidney injury in adult critically ill patients: development, validation and comparison to serum neutrophil gelatinase-associated lipocalin. Intensive Care Med 43:764–773CrossRefPubMed Flechet M, Guiza F, Schetz M, Wouters P, Vanhorebeek I, Derese I, Gunst J, Spriet I, Casaer M, Van den Berghe G, Meyfroidt G (2017) AKIpredictor, an online prognostic calculator for acute kidney injury in adult critically ill patients: development, validation and comparison to serum neutrophil gelatinase-associated lipocalin. Intensive Care Med 43:764–773CrossRefPubMed
16.
17.
Metadata
Title
What’s new in ICU in 2050: big data and machine learning
Authors
Sébastien Bailly
Geert Meyfroidt
Jean-François Timsit
Publication date
01-09-2018
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 9/2018
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-017-5034-3

Other articles of this Issue 9/2018

Intensive Care Medicine 9/2018 Go to the issue